James Investment Research’s Vanguard Health Care ETF VHT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-13
Closed -$3K – 535
2023
Q1
$3K Hold
13
– – ﹤0.01% 531
2022
Q4
$3K Buy
13
+2
+18% +$485 ﹤0.01% 520
2022
Q3
$2K Hold
11
– – ﹤0.01% 503
2022
Q2
$3K Hold
11
– – ﹤0.01% 479
2022
Q1
$3K Hold
11
– – ﹤0.01% 477
2021
Q4
$3K Hold
11
– – ﹤0.01% 485
2021
Q3
$3K Sell
11
-4
-27% -$1.03K ﹤0.01% 470
2021
Q2
$4K Hold
15
– – ﹤0.01% 468
2021
Q1
$3K Hold
15
– – ﹤0.01% 463
2020
Q4
$3K Buy
15
+3
+25% +$641 ﹤0.01% 488
2020
Q3
$2K Buy
12
+1
+9% +$202 ﹤0.01% 458
2020
Q2
$2K Hold
11
– – ﹤0.01% 436
2020
Q1
$2K Sell
11
-2
-15% -$365 ﹤0.01% 450
2019
Q4
$2K Hold
13
– – ﹤0.01% 496
2019
Q3
$2K Hold
13
– – ﹤0.01% 556
2019
Q2
$2K Hold
13
– – ﹤0.01% 654
2019
Q1
$2K Hold
13
– – ﹤0.01% 811
2018
Q4
$2K Buy
+13
New +$2.2K ﹤0.01% 788

Other funds holding VHT

James Investment Research's VHT Position: Q2 2023 in Review

James Investment Research sold out of Vanguard Health Care ETF (VHT) in Q2 2023, closing a stake of 13 shares — an estimated $3K sold.

James Investment Research first reported a position in VHT in Q4 2018 and held it in 18 quarters. The position peaked at $4K in Q2 2021. 923 funds tracked by Wall St. Rank hold VHT as of Q2 2023.

  • James Investment Research reported no remaining Vanguard Health Care ETF position as of Q2 2023 after selling out during the quarter.
  • James Investment Research sold 13 Vanguard Health Care ETF shares in Q2 2023, an estimated $3K.
  • James Investment Research first reported a position in Vanguard Health Care ETF in Q4 2018 and held it in 18 quarters.
  • James Investment Research's Vanguard Health Care ETF position peaked at $4K in Q2 2021.
  • 923 funds tracked by Wall St. Rank held Vanguard Health Care ETF as of Q2 2023.

Based on James Investment Research's 13F filing for Q2 2023, filed 7 Aug 2023.